Phosphorus-Binding Composition for Ruminant Calcium Homeostasis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for reducing the risk of hypocalcemia in periparturient ruminant animals, such as dairy cows, lack precision in adjusting the phosphorus to aluminum (P:Al) ratios in total mixed rations, leading to inconsistent blood phosphorus concentrations and increased risks of metabolic disorders.
Innovation Solution
A method involving the measurement of blood phosphorus concentration in periparturient animals, followed by the administration of a phosphorus-binding compound, particularly an aluminum compound, to control blood phosphorus levels within a specific range (1.5-3.5 mg P per dL) through adjusting the administration rate or reformulating the composition, thereby maintaining optimal P:Al ratios in the diet.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If aluminum-based phosphorus binders are fed to periparturient cows, then blood phosphorus concentration is reduced and calcium homeostasis is improved, but the P:Al ratio in feeds is inconsistent and manufacturing precision deteriorates
Solution Approach 1:
The patent changes the key parameter from variable P:Al ratios to a fixed calcium phosphate content (2-10% of total ration dry matter). This standardized parameter approach ensures consistent calcium and phosphorus binding effects regardless of feed formulation variations, resolving the contradiction between reliability of calcium homeostasis and manufacturing precision of P:Al ratios
Solution Approach 2:
The patent uses calcium phosphate as a standardized model compound that replicates the phosphorus-binding effect of aluminum-based products while providing predictable calcium and phosphorus content. This copying approach with a well-characterized compound eliminates the variability inherent in aluminum-based products, achieving both reliable calcium homeostasis and precise manufacturing
2Reliability
If calcium binders are fed to stimulate parathyroid hormone and vitamin D activation, then the cow's response to blood calcium demand is improved, but actual calcium deficiency is elicited
Solution Approach 1:
The patent applies partial binding of dietary phosphorus (2-10% of total ration dry matter) rather than complete binding. This partial action is sufficient to stimulate parathyroid hormone and vitamin D activation for improved calcium homeostasis, while leaving enough available phosphorus and calcium to prevent actual deficiencies
Solution Approach 2:
The patent changes the approach from complete calcium binding to controlled phosphorus binding with specific calcium phosphate content. This parameter change ensures that calcium is not excessively bound, allowing adequate calcium absorption while still stimulating the necessary homeostatic responses
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach effectively reduces the risk of hypocalcemia by maintaining blood phosphorus concentrations within a targeted range, thereby supporting calcium homeostasis and minimizing the incidence of related metabolic diseases in periparturient animals.
Implementation Method 1
The present invention is directed to a method of reducing risk of periparturient hypocalcemia in a periparturient ruminant animal. The method comprises the steps of a) measuring blood phosphorus (P) concentration in the animal; and, b) administering the composition comprising a phosphorus-binding compound... Through binding phosphorus, with the use of an aluminum-based product, a reduction in blood phosphorus occurs stimulating the homeostatic mechanisms needed by the periparturient cow at calving to respond to the calcium demand challenge.
Data Source
AI summary
A method of reducing risk of periparturient hypocalcemia in a periparturient ruminant animal involves: measuring blood phosphorus concentration in the animal; and, administering a composition containing a phosphorus-binding compound and optionally, a pharmacologically acceptable carrier to the animal during at least part of a prepartum period of the animal, the composition having an effective amount of the phosphorus-binding compound to control the blood phosphorus concentration in a range of 1.5-3.5 mg P per dL of blood in the animal.